Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AP003419.11 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | USP22 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | CCNT2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | TRIM36 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | KIAA1143 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SCAI | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | BOLA2B | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |